549 related articles for article (PubMed ID: 18762555)
41. A novel thyroid transcription factor is essential for thyrotropin-induced up-regulation of Na+/I- symporter gene expression.
Ohmori M; Endo T; Harii N; Onaya T
Mol Endocrinol; 1998 May; 12(5):727-36. PubMed ID: 9605935
[TBL] [Abstract][Full Text] [Related]
42. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.
Furuya F; Shimura H; Suzuki H; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
Endocrinology; 2004 Jun; 145(6):2865-75. PubMed ID: 14976143
[TBL] [Abstract][Full Text] [Related]
43. Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I- symporter messenger ribonucleic acid levels in FRTL-5 cells.
Pekary AE; Hershman JM
Endocrinology; 1998 Feb; 139(2):703-12. PubMed ID: 9449644
[TBL] [Abstract][Full Text] [Related]
44. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
45. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
[TBL] [Abstract][Full Text] [Related]
46. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer.
Knostman KA; Cho JY; Ryu KY; Lin X; McCubrey JA; Hla T; Liu CH; Di Carlo E; Keri R; Zhang M; Hwang DY; Kisseberth WC; Capen CC; Jhiang SM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5196-203. PubMed ID: 15472226
[TBL] [Abstract][Full Text] [Related]
47. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
Jung KH; Paik JY; Ko BH; Lee KH
J Nucl Med; 2008 Dec; 49(12):1966-72. PubMed ID: 18997042
[TBL] [Abstract][Full Text] [Related]
48. New insights about the posttranscriptional mechanisms triggered by iodide excess on sodium/iodide symporter (NIS) expression in PCCl3 cells.
Serrano-Nascimento C; Calil-Silveira J; Goulart-Silva F; Nunes MT
Mol Cell Endocrinol; 2012 Feb; 349(2):154-61. PubMed ID: 22001309
[TBL] [Abstract][Full Text] [Related]
49. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
Kogai T; Schultz JJ; Johnson LS; Huang M; Brent GA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8519-24. PubMed ID: 10890895
[TBL] [Abstract][Full Text] [Related]
50. Transcriptional regulation of human sodium/iodide symporter gene: a role for redox factor-1.
Puppin C; Arturi F; Ferretti E; Russo D; Sacco R; Tell G; Damante G; Filetti S
Endocrinology; 2004 Mar; 145(3):1290-3. PubMed ID: 14630715
[TBL] [Abstract][Full Text] [Related]
51. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
[TBL] [Abstract][Full Text] [Related]
52. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
Kunnimalaiyaan M; Ndiaye M; Chen H
Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
[TBL] [Abstract][Full Text] [Related]
53. PAX8PPARgamma stimulates cell viability and modulates expression of thyroid-specific genes in a human thyroid cell line.
Espadinha C; Cavaco BM; Leite V
Thyroid; 2007 Jun; 17(6):497-509. PubMed ID: 17614769
[TBL] [Abstract][Full Text] [Related]
54. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene.
Suzuki K; Mori A; Saito J; Moriyama E; Ullianich L; Kohn LD
Endocrinology; 1999 Nov; 140(11):5422-30. PubMed ID: 10537174
[TBL] [Abstract][Full Text] [Related]
55. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
56. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.
Kogai T; Endo T; Saito T; Miyazaki A; Kawaguchi A; Onaya T
Endocrinology; 1997 Jun; 138(6):2227-32. PubMed ID: 9165005
[TBL] [Abstract][Full Text] [Related]
57. Identification of cyclic adenosine 3',5'-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer.
Fenton MS; Marion KM; Hershman JM
Endocrinology; 2008 May; 149(5):2592-606. PubMed ID: 18202121
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
59. Propylthiouracil increases sodium/iodide symporter gene expression and iodide uptake in rat thyroid cells in the absence of TSH.
Sue M; Akama T; Kawashima A; Nakamura H; Hara T; Tanigawa K; Wu H; Yoshihara A; Ishido Y; Hiroi N; Yoshino G; Kohn LD; Ishii N; Suzuki K
Thyroid; 2012 Aug; 22(8):844-52. PubMed ID: 22853729
[TBL] [Abstract][Full Text] [Related]
60. Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells.
Li W; Ain KB
Endocr Relat Cancer; 2010 Jun; 17(2):383-98. PubMed ID: 20228127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
